Fresenius SE & Co. KGaAの最新の1株当たり利益は$0.2で、$0.9の予想を殴打しない。
Fresenius SE & Co. KGaA FSNUYの前四半期の収益はどうでしたか?
Fresenius SE & Co. KGaAの前四半期の収益は$0.2です。
Fresenius SE & Co. KGaAの収益見積もりはいくらですか?
6人のウォール街のアナリストによると、Fresenius SE & Co. KGaAの収益見積もりは$6.06Bから$5.59Bの範囲です。
Fresenius SE & Co. KGaAの収益品質スコアはどれくらいですか?
Fresenius SE & Co. KGaAの収益品質スコアは/です。このスコアは、収益性、成長、キャッシュ生成と資本配分、レバレッジの4つの次元に基づいています。
Fresenius SE & Co. KGaAはいつ収益を報告しますか?
Fresenius SE & Co. KGaAの次の収益報告は2026-11-03に予定されています
Fresenius SE & Co. KGaAの予想収益はいくらですか?
ウォール街のアナリストによると、Fresenius SE & Co. KGaAの予想収益は$5.91Bです。
Fresenius SE & Co. KGaAは収益予想を上回りましたか?
Fresenius SE & Co. KGaAの最近の収益は$5.98Bで、予想をビート。
主要データ
前終値
$13.56
始値
$13.48
当日レンジ
$13.48 - $13.66
52週レンジ
$10.33 - $33.93
取引高
37.1K
平均取引高
226.2K
配当利回り
--
1株当たり利益(TTM)
0.80
時価総額
$30.6B
Fresenius SE & Co. KGaAとは何ですか?
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg, Hessen and currently employs 178,394 full-time employees. The firm has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.